These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16542792)

  • 1. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
    Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
    Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
    Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
    Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
    Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
    Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
    Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
    Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients.
    Gao L; Xu GZ; Yin WB; Yan JH; Cai WM; Gu XZ
    Chin Med J (Engl); 1993 Jun; 106(6):467-70. PubMed ID: 8222900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
    Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients].
    Cao X; Chen K; He Z
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
    Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate brachytherapy boost for primary nasopharyngeal carcinoma: preliminary results of an ongoing prospective study.
    Malde R; Agarwal JP; Laskar SG; Gupta T; Dinshaw K
    Bull Cancer; 2005 Jul; 92(7):E45-50. PubMed ID: 16122998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
    Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
    Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
    Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
    Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy.
    Palazzi M; Guzzo M; Tomatis S; Cerrotta A; Potepan P; Quattrone P; Cantù G
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1451-8. PubMed ID: 15590176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
    Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
    Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
    Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
    Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
    Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
    Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.